About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Illinois | 390 Studies

Clinical Trials Colorectal CancerIllinois

Colorectal Cancer Clinical Trials in Illinois

Find 390 clinical trials for colorectal cancer near Illinois. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-300 of 390 trials

RecruitingSafely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing ChemotherapyThis is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injection in up to 120 patients.NCT06937177·Tucson, Arizona and 25 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedOutreach for Patients That Are Newly Eligible for Colorectal Cancer ScreeningThe purpose of this study is to evaluate whether patient outreach is effective at increasing compliance with preventative screenings for those patients who, based on national…NCT00860249·Chicago, Illinois

Active not recruitingEvaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).The purpose of this study is to assess the efficacy and safety of co-formulated pembrolizumab/quavonlimab versus other treatments in participants with MSI-H or dMMR Metastatic…NCT04895722·Orange City, Florida and 108 others

CompletedCalcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination ChemotherapyRATIONALE: Chemoprotective drugs, such as calcium gluconate and magnesium sulfate, may prevent neurotoxicity caused by oxaliplatin.NCT01099449·Fairbanks, Alaska and 404 others

CompletedA Study in Second Line Metastatic Colorectal CancerThe purpose of this study is to compare overall survival in participants with metastatic colorectal cancer treated with either ramucirumab and FOLFIRI or placebo and FOLFIRI.NCT01183780·Sedona, Arizona and 212 others

CompletedSample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)The primary objective of this study is to gather stool samples from subjects with inflammatory bowel disease (IBD) to be added to a test set of stool samples that will be utilized…NCT02503696·Dothan, Alabama and 28 others

CompletedRedes III Patient Navigator Qol StudyThis proposed 5-year Redes En Acción research study involves a mixed-methods approach that occurs in two phases across two distinct and diverse HL communities.NCT02275754·Chicago, Illinois and 1 other

RecruitingA Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsThis is a first-in-human, Phase I, open-label, multicenter, dose-escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and…NCT06004245·Tucson, Arizona and 46 others

CompletedPlan to Thrive: Extending Cancer Survivorship Care Beyond the ClinicThe purpose of this study is to test the usability of the Plan To Thrive smartphone application with cancer survivors.NCT03996031·Chicago, Illinois

CompletedA Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic MalignanciesThis is an open-label, Phase I, dose-escalation study to determine the maximum tolerated dose (MTD) and/or recommended phase two dose (RPTD), and evaluate the safety, efficacy…NCT03082209·New Haven, Connecticut and 18 others

CompletedEndoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionRATIONALE: The use of endoscopy to place a metal stent in the large intestine is less invasive than surgery for treating cancer-related bowel obstruction and may have fewer side…NCT00004911·Chicago, Illinois

TerminatedA Study of ASP1951 in Subjects With Advanced Solid TumorsThe primary purpose of this study is to evaluate the tolerability and safety profile of ASP1951 when administered as a single agent and in combination with pembrolizumab in…NCT03799003·Tucson, Arizona and 31 others

TerminatedInformed Choice - CompassThe primary objective of this study is to evaluate the impact of a theoretically grounded video that includes information about CRC screening modality choices on CRC screening…NCT05246839·Phoenix, Arizona and 38 others

CompletedPEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsThe primary objective of this study is to estimate the treatment effect on progression-free survival (PFS) of panitumumab relative to bevacizumab in combination with mFOLFOX6…NCT00819780·Birmingham, Alabama and 94 others

CompletedStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyStudy of NGM120 in subjects with advanced solid tumors and pancreatic cancer (Part 1 and 2) and metastatic castration resistant prostate cancer (Part 3).NCT04068896·Tucson, Arizona and 19 others

TerminatedPhase 1 Combination Study of MM-151 With MM-121, MM-141, or TrametinibThis is a Phase 1 open-label, dose-escalation trial using "3+3" design, evaluating MM-151 co-administration with MM-121, MM-141, and trametinib at varying dose levels.NCT02538627·Aurora, Colorado and 4 others

TerminatedCombination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By SurgeryRATIONALE: Drugs used in chemotherapy work in different ways to kill tumor cells or stop them from growing.NCT01189227·Antioch, California and 282 others

CompletedBlood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act FastThe primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of…NCT03789162·Phoenix, Arizona and 44 others

UnknownStudy of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 StatusThis is a phase II trial to examine the efficacy of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (all RAS/NRAS/BRAF/PIK3CA…NCT03457896·Anaheim, California and 47 others

CompletedSWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003254·Mobile, Alabama and 85 others

PreviousPage 15 of 20Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma